Physician

Christopher Sean Thompson, M.D.

According to 2025 Medicare claims, Christopher Thompson, M.D. (NPI: 1225135478) practices cardiology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is IMPERIAL HEALTH, LLP (NPI: 1053352401; TIN: 721005645) and primary practice location at 70663-3503.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,200 traditional Medicare patients, billed 5,562 HCPCS/CPT codes, and received $292,134 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,999 prescription claims across 868 beneficiaries totaling $1,161,637 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 17 claims. Open Payments data shows 14 records totaling $272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $520,818 to $292,134. In contrast, Part D prescription costs have risen steadily, from $564,112 to $1,161,637. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $57,554 and ending at $38,076.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,449	9,766	$520,818
2016	3,533	10,224	$499,489
2017	3,374	9,848	$516,405
2018	3,350	9,352	$473,394
2019	3,257	9,115	$495,644
2020	2,398	6,317	$358,800
2021	2,444	6,838	$422,985
2022	2,519	7,003	$396,723
2023	2,155	6,094	$349,053
2024	2,200	5,562	$292,134

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	723	6,330	$564,112
2016	755	5,809	$681,266
2017	724	5,792	$685,742
2018	717	5,681	$681,396
2019	711	5,392	$736,798
2020	733	5,782	$906,419
2021	840	6,000	$1,002,272
2022	850	6,292	$1,149,991
2023	853	6,023	$1,175,494
2024	868	5,999	$1,161,637

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$57,464
2016	N/R	14	$27,699
2017	12	33	$69,001
2018	N/R	15	$30,966
2019	N/R	17	$38,076
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	917	954	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	642	663	$86
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	168	168	$10
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	881	1,028	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	864	1,078	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	711	34,633	$666,035
Xarelto	Rivaroxaban	201	8,615	$158,100
Entresto	Sacubitril/Valsartan	107	4,089	$89,276
Repatha Sureclick	Evolocumab	110	4,368	$83,877
Nexlizet	Bempedoic Acid/Ezetimibe	45	2,130	$28,944

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$272	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Sean Thompson, M.D.?

Tedicare shows public-source Medicare data for Christopher Sean Thompson, M.D. (NPI 1225135478), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Sean Thompson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Sean Thompson, M.D.?

Christopher Sean Thompson, M.D. is linked to IMPERIAL HEALTH, LLP (billing NPI 1053352401) in the available physician profile data.

Does Christopher Sean Thompson, M.D. have Open Payments data?

Christopher Sean Thompson, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.